• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Hepatic Usp2 Promotes Lipid Accumulation Through G3bp2 Protein Stabilization

by
November 16, 2026
in Biology, Health
Reading Time: 2 mins read
0
Hepatic Usp2 Promotes Lipid Accumulation Through G3bp2 Protein Stabilization

Hepatic Usp2 Promotes Lipid Accumulation Through G3bp2 Protein Stabilization

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Metabolic dysfunction-associated fatty liver disease (MAFLD) and related metabolic conditions, such as obesity and type 2 diabetes, represent an escalating global health challenge that necessitates the identification of precise therapeutic targets. Elevated hepatic de novo lipogenesis (DNL) is recognized as a hallmark of this dysfunction, yet the complexity of the transcriptional and enzymatic components involved has historically made clinical intervention difficult. Researchers have now identified that the ubiquitin-specific protease 2 (Usp2) enzyme acts as a critical regulator of this process, providing new insight into the molecular mechanisms that drive lipid accumulation within the liver.

Using a multi-model comparative transcriptomic strategy, the study highlights that Usp2 is consistently upregulated in liver tissues and shows a strong correlation with the severity of hepatic steatosis. Functional assessments conducted both in vitro and in vivo confirmed that the presence and activity of Usp2 directly facilitate increased lipid accumulation. These findings suggest that the protein plays a functional role in promoting the metabolic changes that characterize the progression of fatty liver disease.

Mechanistically, the research characterizes a specific regulatory pathway involving the Usp2-G3bp2-β-catenin axis. Usp2 has been shown to interact directly with the RNA-binding protein G3bp2, stabilizing it through a process of K63-linked deubiquitination. This stabilization results in the activation of β-catenin signaling, which subsequently triggers the upregulation of essential lipogenic genes, including Fasn, Scd1, and Plin2. By maintaining the stability of these regulatory proteins, Usp2 effectively orchestrates the genetic environment required for increased de novo lipogenesis.

These results establish a previously unrecognized regulatory axis that drives hepatic lipogenesis and nominate Usp2 as a potentially viable therapeutic target for metabolic diseases. Because targeting core transcriptional and enzymatic components of lipogenesis has proven challenging in clinical settings, the identification of this specific protease pathway offers a potential alternative strategy for addressing the underlying drivers of metabolic dysfunction in the liver.

Methodologically, the study design separated correlational transcriptomic screening from causal functional testing across laboratory models. The comparative transcriptomic analysis identified consistent protease upregulation that correlated directly with steatosis severity across diverse model systems. To determine whether this association reflected active metabolic regulation, subsequent functional experiments confirmed that enzyme expression promotes hepatic lipid accumulation in both cell culture assays and living animal models.

Mechanistically, stabilizing the target protein activates downstream signaling to upregulate specific lipogenic factors. However, because these demonstrations remain restricted to laboratory cell and animal models, they do not establish human clinical outcomes.

Subject of Research: Molecular mechanisms of hepatic de novo lipogenesis in metabolic disease

Article Title: Hepatic Usp2 orchestrates de novo lipogenesis through G3bp2 stabilization and β-catenin activation

Article References: Wang, W., Wang, H., Liu, Y., Cui, S., Tang, C., Wang, M., Mu, C., Li, J., Ye, X., Liang, X., & Zhu, S. (2026). Hepatic Usp2 orchestrates de novo lipogenesis through G3bp2 stabilization and β-catenin activation. Cell Death Discovery. https://doi.org/10.1038/s41420-026-03333-2

Image Credits: AI Generated

DOI: 10.1038/s41420-026-03333-2

Keywords: Usp2, G3bp2, beta-catenin, hepatic steatosis, de novo lipogenesis, metabolic disease, MAFLD, lipid metabolism, deubiquitination, transcriptomic analysis, Fasn, Scd1, Plin2, liver health, metabolic regulation

News Source: Drew Townsend. (November 16, 2026). Hepatic Usp2 Promotes Lipid Accumulation Through G3bp2 Protein Stabilization. Scienmag.

Tags: beta-cateninde novo lipogenesisDeubiquitinationFASNG3BP2hepatic steatosislipid metabolismLiver HealthMAFLDmetabolic diseaseMetabolic regulationPLIN2SCD1transcriptomic analysisUsp2
Share12Tweet7Share2ShareShareShare1

Related Posts

Interferon-Induced LAP3 Promotes Mouse Embryo Resorption by Inhibiting Trophoblast Mitophagy

Interferon-Induced LAP3 Promotes Mouse Embryo Resorption by Inhibiting Trophoblast Mitophagy

November 16, 2026
Biliary Fascioliasis Mimics Bile Duct Stones: Insights from Four Clinical Cases

Biliary Fascioliasis Mimics Bile Duct Stones: Insights from Four Clinical Cases

November 16, 2026

Physical Fitness Declined Among Belgian Children Between 2004 and 2022

November 16, 2026

AlphaFold3 Outperforms Conventional Tools in Predicting Adeno-Associated Virus Capsid Structures

November 16, 2026

POPULAR NEWS

  • Urban Expansion Across Sub-Saharan Africa Fuels Complex Malaria Transmission Risks

    Urban Expansion Across Sub-Saharan Africa Fuels Complex Malaria Transmission Risks

    29 shares
    Share 12 Tweet 7
  • Distinct Nesprin Isoforms Govern Nuclear Positioning and Mechanics in Striated Muscle

    29 shares
    Share 12 Tweet 7
  • Language Model Simulation Links Control Prompts to Synthetic Quiet Quitting Risk

    29 shares
    Share 12 Tweet 7
  • Standardized Metrics Needed to Prioritize Own Mother’s Milk in Neonatal Units

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Interferon-Induced LAP3 Promotes Mouse Embryo Resorption by Inhibiting Trophoblast Mitophagy

Systematic Review Outlines Artificial Intelligence Strategies for Designing Functional Taste Peptides

Biliary Fascioliasis Mimics Bile Duct Stones: Insights from Four Clinical Cases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.